ARTG 465985Peripheral venous endovascular stent-graft
ARTG ID: 465985 · Bard Australia Pty Ltd · Angiomed GmbH & Co Medizintechnik KG · Class IIb · Started October 25, 2024
Good Name: Bard Australia Pty Ltd - Peripheral venous endovascular stent-graft
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 465985
- Start Date
- October 25, 2024
- Effective Date
- October 25, 2024
- Country
- Germany
- Address
- Wachhausstrasse 6, KARLSRUHE, 76227
The device is intended to restore and maintain the venous outflow of hemodialysis access circuits. It is indicated for use in hemodialysis patients for the treatment of stenoses in the venous outflow of an arterio-venous (AV) fistula and at the venous anastomosis of an ePTFE or other synthetic AV graft.
Access comprehensive regulatory information for Peripheral venous endovascular stent-graft in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 465985 and sponsored by Bard Australia Pty Ltd, manufactured by Angiomed GmbH & Co Medizintechnik KG in Germany. The device registration started on October 25, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.